Newly Identified Transcriptomic Biomarkers and Gene Signature of Pathological Complete Response to Induction Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
Saved in:
| Title: | Newly Identified Transcriptomic Biomarkers and Gene Signature of Pathological Complete Response to Induction Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. |
|---|---|
| Authors: | Zhou JG; Department of Oncology The Second Affiliated Hospital of Zunyi Medical University Zunyi China.; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Erlangen Germany.; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; FAU Profile Center Immunomedicine (FAU I-MED) Friedrich-Alexander- Universität Erlangen-NüRnberg Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany., Eckstein M; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany.; Institute of Pathology, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Erlangen Germany., Wang H; Center For Precision Medicine Research and Training, Faculty of Health Sciences University of Macau Macau SAR China., Lan T; Department of Oral and Maxillofacial Surgery Sun Yat-sen Memorial Hospital of Sun Yat-Sen University Guangzhou China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory For RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital Sun Yat-sen University Guangzhou China., Frey B; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Erlangen Germany.; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; FAU Profile Center Immunomedicine (FAU I-MED) Friedrich-Alexander- Universität Erlangen-NüRnberg Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany., Li X; Department of Radiotherapy and Radiation Oncology Saarland University Medical Center Homburg/Saar Germany., Lu X; Department of Cancer and Functional Genomics Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA Illkirch France., Klautke G; Department of Radiation Oncology Hospital Chemnitz Chemnitz Germany., Illmer T; Private Praxis Oncology Arnoldstraße Dresden Germany., Fleischmann M; Department of Radiation Oncology University Hospital Frankfurt, Goethe-Universität Frankfurt Frankfurt am Main Germany., Laban S; Department of Otolaryngology - Head & Neck Surgery University Hospital Ulm Universität Ulm Ulm Germany., Hautmann MG; Department of Radiotherapy University Hospital Regensburg Regensburg Germany.; Department of Radiotherapy and Radiation Oncology Hospital Traunstein Traunstein Germany., Tamaskovics B; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf Heinrich Heine University Düsseldorf Germany., Brunner TB; Department of Radiation Oncology Medical University of Graz Graz Austria.; Department of Radiation Oncology University Hospitals Magdeburg Magdeburg Germany., Hartmann A; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; FAU Profile Center Immunomedicine (FAU I-MED) Friedrich-Alexander- Universität Erlangen-NüRnberg Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany.; Institute of Pathology, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Erlangen Germany., Fietkau R; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany.; Department of Radiation Oncology, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Erlangen Germany., Ma H; Department of Oncology The Second Affiliated Hospital of Zunyi Medical University Zunyi China., Gostian AO; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany.; Department of Otolaryngology - Head & Neck Surgery, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Elangen Germany.; Department of Otolaryngology - Head & Neck Surgery Hospital Straubing Straubing Germany., Iro H; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany.; Department of Otolaryngology - Head & Neck Surgery, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Elangen Germany., Hecht M; Department of Radiotherapy and Radiation Oncology Saarland University Medical Center Homburg/Saar Germany., Gaipl US; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Erlangen Germany.; Comprehensive Cancer Center Erlangen-EMN Erlangen Germany.; FAU Profile Center Immunomedicine (FAU I-MED) Friedrich-Alexander- Universität Erlangen-NüRnberg Erlangen Germany.; Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum, BZKF) Erlangen Germany. |
| Source: | MedComm [MedComm (2020)] 2026 Jan 14; Vol. 7 (1), pp. e70582. Date of Electronic Publication: 2026 Jan 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2688-2663 |
|---|---|
| DOI: | 10.1002/mco2.70582 |
